#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4874	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2328	607.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1735	1735	T	700	T,C,A	617,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	4874	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2328	607.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1469	1469	C	723	C,A	616,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	0	.	n	.	0	T695C	SNP	695	695	T	1189	1189	C	544	C,G,A	468,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1831	1831	A	642	A,T	566,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2465	2465	C	774	C,T	676,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3091	3091	T	738	T,A,G	625,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2539	2539	A	824	A	714	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7956	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3877	613.5	0	HET	.	.	.	C393T	.	393	393	C	887	887	C	609	C,T	388,142	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	786	folP	852	852	99.88	folP.l15.c4.ctg.1	1931	121.9	0	.	p	.	0	S68P	NONSYN	202	204	TCG	704	706	CCG	184;184;185	C,G;C,T;G	158,1;160,1;170	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	786	folP	852	852	99.88	folP.l15.c4.ctg.1	1931	121.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1184	1186	AGC	164;163;164	A;G;C	136;137;135	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1620	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3816	127.3	1	SNP	p	S91F	1	.	.	271	273	TTC	780	782	TTC	141;142;143	T;T;C	122;124;128	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1620	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3816	127.3	1	SNP	p	N95G	0	.	.	283	285	AAC	792	794	AAC	145;146;147	A;A;C	128;127;130	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1620	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3816	127.3	1	SNP	p	D95N	1	.	.	283	285	AAC	792	794	AAC	145;146;147	A;A;C	128;127;130	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	640	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1851	103.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	410	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1446	85.0	0	.	n	.	0	T10C	SNP	10	10	T	596	596	C	170	C	145	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	410	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c4.ctg.1	1446	85.0	0	.	n	.	0	A197.	DEL	197	197	A	782	782	A	167	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	164.3	1	SNP	p	D86N	0	.	.	256	258	GAC	698	700	GAC	245;244;244	G;A;C	199;190;201	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	164.3	1	SNP	p	R87I	0	.	.	259	261	CGT	701	703	CGT	245;245;243	C;G;T	199;201;192	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	164.3	1	SNP	p	S87R	1	.	.	259	261	CGT	701	703	CGT	245;245;243	C;G;T	199;201;192	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	164.3	1	SNP	p	R87W	0	.	.	259	261	CGT	701	703	CGT	245;245;243	C;G;T	199;201;192	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1814	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	164.3	1	SNP	p	S88P	0	.	.	262	264	TCC	704	706	TCC	244;244;244	T;C,A;C,A	196;198,1;204,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1424	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3013	141.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1712	1714	GGC	183;181;181	G,C;G;C	157,1;153;154	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1565	1567	GCA	176;175;175	G,T;C;A,C	153,1;157;158,1	penA.3.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1568	1570	ATC	174;174;173	A,C;T,C;C	156,1;150,1;154	penA.3.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1580	1582	GTG	176;176;179	G,A;T,C;G,C	158,1;150,1;161,1	penA.3.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1580	1582	GTG	176;176;179	G,A;T,C;G,C	158,1;150,1;161,1	penA.3.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2084	2086	ACC	159;160;160	A,C;C;C,A	137,1;144;140,1	penA.3.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	A502V	1	.	.	1504	1506	GTG	2138	2140	GTG	161;160;160	G;T,G;G	135;118,2;125	penA.3.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	V502P	0	.	.	1504	1506	GTG	2138	2140	GTG	161;160;160	G;T,G;G	135;118,2;125	penA.3.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2261	2263	GGC	155;154;153	G,C;G,T;C	119,1;124,1;124	penA.3.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2270	2272	GGC	157;158;160	G;G;C	125;130;130	penA.3.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.3.001	penA.3.001	1	1	27	1230	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2951	124.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2288	2290	CCG	164;165;163	C;C;G,T	121;135;125,1	penA.3.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1638	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3441	142.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1786	1788	CCG	157;157;157	C,G;C;G,T	128,1;130;129,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	852	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2302	110.8	0	.	p	.	0	A17T	NONSYN	49	51	GCA	650	652	ACA	137;138;136	A;C;A	117;122;119	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	852	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2302	110.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	665	667	GGC	131;131;133	G;G;C	115;116;113	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	852	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2302	110.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	847	847	C	124	C	113	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	T26A	NONSYN	76	78	ACC	516	518	GCC	229;230;230	G;C,T;C	198;200,1;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	552	554	GAA	229;229;229	G,T;A;A	202,1;193;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	T40R	NONSYN	118	120	ACA	558	560	CGG	232;232;233	C;G;G	202;199;204	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	K41E	NONSYN	121	123	AAA	561	563	GAA	232;231;231	G;A;A	198;200;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	S45V	NONSYN	133	135	AGT	573	575	GTT	241;239;240	G;T;T	210;207;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	K46G	NONSYN	136	138	AAA	576	578	GGC	241;241;240	G;G;C	212;209;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	582	584	GGA	247;247;247	G,T;G;A	209,1;211;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	A54S	NONSYN	160	162	GCC	600	602	TCC	242;244;244	T,G;C;C	197,2;209;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	963	965	TCA	233;233;233	T;C,T;A	197;205,1;199	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1092	1094	GTC	228;228;229	G;T;C	204;211;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	1	SNP	p	G120K	1	.	.	358	360	AAG	798	800	AAG	228;227;228	A,C;A;G	199,1;199;203	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	1	SNP	p	D121N	0	.	.	361	363	GAC	801	803	GAC	229;229;228	G;A;C	199;203;203	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	1142	porB1b	1047	1047	98.19	porB1b.l15.c30.ctg.1	1742	190.1	1	SNP	p	A121D	1	.	.	361	363	GAC	801	803	GAC	229;229;228	G;A;C	199;203;203	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	3048	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5225	174.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	506	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1344	112.5	1	SNP	p	V57M	1	.	.	169	171	ATG	677	679	ATG	208;208;208	A;T;G,T	180;177;175,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
